четверг, 9 марта 2017 г.

Heat Biologics acquires Texas biotech Pelican Therapeutics

Heat Biologics acquires Texas biotech Pelican Therapeutics


Durham-based biotechnology company Heat Biologics Inc. agreed on Wednesday to acquire a controlling interest in the Austin, Texas-based biotech company Pelican Therapeutics Inc., the company said in a release. Heat Biologics, which is focused on the field of cancer immunotherapy, said it had agreed to pay participating Pelican Therapeutics stockholders an upfront cash payment not to exceed $500,000 and will issue more than $1.3 million shares of Heat Biologics common stock for an 80 percent controlling interest in Pelican Therapeutics.



from Biotech News